Zoetis to Participate in the William Blair 44th Annual Growth Stock Conference

Business Wire
Focus Announces That Five U.S. Business Lines of Connectus Wealth Advisers Have Joined The Colony Group
NEW YORK, June 03, 2024--Focus Financial Partners Inc., a leading partnership of fiduciary wealth management and related financial services firms, announced today that five U.S.-based business lines within partner firm Connectus Wealth Advisers have formally joined Focus firm The Colony Group, LLC.
Business Wire
Bridge Investment Group Announces Hiring of Alison Brown as President of Bridge Property Management and Deputy Chief Investment Officer for Bridge Workforce and Affordable Housing Strategy
SALT LAKE CITY, June 03, 2024--Bridge Investment Group Holdings Inc. (NYSE: BRDG) ("Bridge" or the "Company") today announced Alison Brown will be joining the Company as President of Bridge Property Management and Deputy Chief Investment Officer for Bridge’s Workforce and Affordable Housing Strategy, effective July 1, 2024.
Business Wire
Coya Therapeutics Announces Acceptance of Peer-Reviewed Manuscript in the Medical Journal: Frontiers in Neurology
HOUSTON, June 03, 2024--Coya Therapeutics, Inc. (NASDAQ: COYA) ("Coya" or the "Company"), a clinical-stage biotechnology company developing biologic intended to enhance regulatory T cell (Treg) function, announces the acceptance of a peer-reviewed manuscript titled, "A Phase 1 Proof-of-Concept Study Evaluating Safety, Tolerability, and Biological Marker Responses with Combination Therapy of CTLA4-Ig and Interleukin-2 in Amyotrophic Lateral Sclerosis," in the medical journal Frontiers in Neurolog
Business Wire
Thermo Fisher Scientific Unveils New Solutions Supporting Research Workflows at ASMS 2024
ANAHEIM, Calif., June 03, 2024--To help accelerate the promise of precision medicine, Thermo Fisher Scientific today unveiled its new solutions accelerating research workflows at the annual American Society for Mass Spectrometry (ASMS) Conference on Mass Spectrometry and Allied Topics, in Anaheim, California. The new mass spectrometry and chromatography instruments and software solutions enable customers to unlock deeper analytical insights with built-for-purpose flexibility, improving productiv
GlobeNewswire
The Cryptocurrency You Shouldn't Miss Next to Bitcoin and Solana! Which Cryptocurrency Will Shape Your Future?
New York City, NY, June 03, 2024 (GLOBE NEWSWIRE) -- As Bitcoin, Ethereum and Solana proceed to be the cornerstones of the cryptocurrency advertise, a modern player, Furrever Token, has risen. This article points to teach perusers on the contrasts and likenesses between these cryptocurrencies, with a special focus on what Furrever Token needs to offer. Solana on the Rise: Poised to Break $170 and Target $200 Solana cost has declined significantly within the past week as crypto speculators divert
Business Wire
Equitable Holdings Announces Cash Tender Offer for Up to $500 Million Aggregate Purchase Price of Its Debt Securities
NEW YORK, June 03, 2024--Equitable Holdings Announces Cash Tender Offer for Up to $500 Million Aggregate Purchase Price of its Debt Securities
GlobeNewswire
Autonomix Announces Approval of Protocol Amendment by Ethics Committee Upon Completion of All Lead-In Patients in Ongoing Human Clinical Trial
Company plans to release topline results from “lead-in” patients (n=5) imminently THE WOODLANDS, TX, June 03, 2024 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company focused on advancing innovative technologies to revolutionize how diseases involving the nervous system are diagnosed and treated, today announced it has received Ethics Committee approval of the protocol amendment for its ongoing proof-of-concept (PoC) human clinical
Business Wire
NorthCoast Asset Management, a Business Line of Connectus Wealth Advisers, Joins Kovitz
NEW YORK, June 03, 2024--Focus Financial Partners Inc., a leading partnership of fiduciary wealth management firms and related financial services firms, announced today that the NorthCoast Asset Management business line of Connectus Wealth Advisers, headquartered in Greenwich, Connecticut, has formally joined fellow Focus firm Kovitz Investment Group Partners, LLC.
Business Wire
Net Asset Value(s)
LONDON, June 03, 2024-- FundsDate
GlobeNewswire
AUROBAC THERAPEUTICS Presents its R&D Strategy & Pipeline and Announces New Development Program in Partnership with Boehringer Ingelheim
AUROBAC THERAPEUTICS to advance ATX101 in septic shock, and multiple preclinical and discovery programs targeting Gram-negative pathogens. Lyon (France), June 3, 2024 AUROBAC THERAPEUTICS, a biopharmaceutical company founded by Boehringer Ingelheim, bioMérieux and Evotec, presented its strategy for the first time today. It aims to address high unmet medical needs associated with infections in acute hospital settings, amidst the growing antimicrobial resistance (AMR) epidemic. AUROBAC THERAPEUTIC
Investor's Business Daily
Dow Jones Futures: Nvidia, AMD Rise After CEOs Tout AI Chip Roadmaps
Futures loom after the stock market showed resilience Friday. Nvidia CEO Huang made a big AI speech Sunday. Tesla EV rivals stepped up sales.
Evening Standard
Dolev Yehud: Hostage who went missing during Hamas attack found dead as US pushes ceasefire plan
Dolev Yehud, 35, was thought to be among scores of hostages held in Gaza
BBC
Donald Trump joins TikTok despite previously wanting ban
The former president joins the current US leader in using the platform despite backing concerns.
Business Wire
Debiopharm and Genome & Company Reach Agreement for Potential First-In Class Oncology Antibody Drug Conjugate Family
LAUSANNE, Switzerland & SUWON-SI GYEONGGI-DO, South Korea, June 03, 2024--Debiopharm (www.debiopharm.com), a privately-owned, Swiss-based, biopharmaceutical company aiming to establish tomorrow’s standard-of-care to cure cancer and infectious diseases, today announced the signing of an exclusive licensing agreement with Genome & Company (http://genomecom.co.kr/), a publicly-traded, South Korea-based, biotechnology company focusing on discovery and development of novel target antibody therapeutic
GlobeNewswire
Molecular Templates, Inc. Provides Interim Update
Continued monotherapy activity in solid tumors with MT-6402 (PD-L1-targeting ETB) in checkpoint-experienced patients.Early pre-clinical and clinical data demonstrate the potential of MT-0169 (CD38-targeting ETB) in severe immune-mediated diseases. AUSTIN, Texas, June 03, 2024 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”), a clinical-stage company focused on the discovery and development of targeted biologic therapeutics with unique mechanisms of a
Evening Standard
Dementia victim is latest to fall foul of fast-track courts
Hundreds of thousands of convictions continue to be handed out behind closed doors
Business Wire
Jemperli (dostarlimab-gxly) trial continues to show unprecedented results with no evidence of disease in 100% of patients with locally advanced mismatch repair deficient (dMMR) rectal cancer
PHILADELPHIA, June 03, 2024--Jemperli trial continues to show unprecedented results with no evidence of disease in 100% of patients with locally advanced dMMR rectal cancer
GlobeNewswire
Maris-Tech Receives New Order for $225,000 From a Military Drone Manufacturer for a Unique Solution for Unmanned Aircraft Systems
The advanced video payload ‎for drones will be based on Maris-Tech’s Uranus technology Rehovot, Israel, June 03, 2024 (GLOBE NEWSWIRE) -- Maris-Tech Ltd. (Nasdaq: MTEK) ("Maris-Tech" or the "Company"), a B2B provider of edge computing artificial intelligence (“AI”) accelerated video solutions for edge platforms, today announced that it has received an order for $225,000 from Aero Sol, a leading military drone manufacturer, for a new video payload solution for drone platforms. Maris-Tech will pro
Evening Standard
How to negotiate: A Masterclass with Simon Horton
Learn science-backed strategies for success with one of the world’s leading negotiators
GlobeNewswire
Form 8.3 - [KEYWORDS STUDIOS PLC - 31 05 2024] - (CGWL)
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser:CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be

NZX 50

NZD/USD

ALL ORDS

OIL

GOLD

Zoetis to Participate in the William Blair 44th Annual Growth Stock Conference

Latest stories

Focus Announces That Five U.S. Business Lines of Connectus Wealth Advisers Have Joined The Colony Group

Bridge Investment Group Announces Hiring of Alison Brown as President of Bridge Property Management and Deputy Chief Investment Officer for Bridge Workforce and Affordable Housing Strategy

Coya Therapeutics Announces Acceptance of Peer-Reviewed Manuscript in the Medical Journal: Frontiers in Neurology

Thermo Fisher Scientific Unveils New Solutions Supporting Research Workflows at ASMS 2024

The Cryptocurrency You Shouldn't Miss Next to Bitcoin and Solana! Which Cryptocurrency Will Shape Your Future?

Equitable Holdings Announces Cash Tender Offer for Up to $500 Million Aggregate Purchase Price of Its Debt Securities

Autonomix Announces Approval of Protocol Amendment by Ethics Committee Upon Completion of All Lead-In Patients in Ongoing Human Clinical Trial

NorthCoast Asset Management, a Business Line of Connectus Wealth Advisers, Joins Kovitz

Net Asset Value(s)

AUROBAC THERAPEUTICS Presents its R&D Strategy & Pipeline and Announces New Development Program in Partnership with Boehringer Ingelheim

Dow Jones Futures: Nvidia, AMD Rise After CEOs Tout AI Chip Roadmaps

Dolev Yehud: Hostage who went missing during Hamas attack found dead as US pushes ceasefire plan

Donald Trump joins TikTok despite previously wanting ban

Debiopharm and Genome & Company Reach Agreement for Potential First-In Class Oncology Antibody Drug Conjugate Family

Molecular Templates, Inc. Provides Interim Update

Dementia victim is latest to fall foul of fast-track courts

Jemperli (dostarlimab-gxly) trial continues to show unprecedented results with no evidence of disease in 100% of patients with locally advanced mismatch repair deficient (dMMR) rectal cancer

Maris-Tech Receives New Order for $225,000 From a Military Drone Manufacturer for a Unique Solution for Unmanned Aircraft Systems

How to negotiate: A Masterclass with Simon Horton

Form 8.3 - [KEYWORDS STUDIOS PLC - 31 05 2024] - (CGWL)